jnj-67856633
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 3, 2019 (NCT03900598)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06788509 | Phase 1 | Dec 30, 2024 | Johnson and Johnson |
| NCT04876092 | Phase 1 | Jul 28, 2021 | Janssen Pharmaceutica NV |
| NCT04657224 | Phase 1 | Dec 28, 2020 | Janssen Pharmaceutica NV |
| NCT03900598 | Phase 1 | Apr 3, 2019 | Johnson and Johnson |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Janssen Pharmaceutica NV | For profit | 2 | 2 | 1 | 2020 |
| Johnson and Johnson | For profit | 2 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1